Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Wohlfahrt

Showing results (31-40 of 72) with videos related to

Pageof 8
Sort By:
American Journal of Epidemiology|December 22, 1999
Reproductive history and stage of breast cancerJ Wohlfahrt, P K Andersen, H T Mouridsen, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|March 16, 2000
Variations in prognostic factors in primary breast cancer throughout the menstrual cycleN Kroman, S M Thorpe, J Wohlfahrt, et al.
Schizophrenia Research|May 18, 2001
Risk factors and confounders in the geographical clustering of schizophreniaE F Torrey, P B Mortensen, C B Pedersen, et al.
British Journal of Cancer|March 6, 2015
Mitochondrial dysfunction and risk of cancerM Lund, M Melbye, L J Diaz, et al.
BMJ (Clinical Research Ed.)|November 14, 1997
Time since childbirth and prognosis in primary breast cancer: population based studyN Kroman, J Wohlfahrt, K W Andersen, et al.
British Journal of Cancer|December 4, 1998
Parity, age at first childbirth and the prognosis of primary breast cancerN Kroman, J Wohlfahrt, K W Andersen, et al.
Scandinavian Journal of Infectious Diseases|May 12, 2001
Intensive exposure as a risk factor for severe polio: a study of multiple family casesN M Nielsen, P Aaby, J Wohlfahrt, et al.
BMJ (Clinical Research Ed.)|March 4, 2000
Factors influencing the effect of age on prognosis in breast cancer: population based studyN Kroman, M B Jensen, J Wohlfahrt, et al.
The Journal of General Virology|August 6, 2010
N-(3-Cyanophenyl)-2-phenylacetamide, an effective inhibitor of morbillivirus-induced membrane fusion with low cytotoxicityK Singethan, G Hiltensperger, S Kendl, et al.
Ugeskrift for Laeger|June 13, 2000
[Should all younger patients with breast cancer be offered adjuvant cytotoxic chemotherapy?]N T Kroman, M B Jensen, J Wohlfahrt, et al.
Pageof 8

Showing results (31-40 of 72) with videos related to

Sort By:
Pageof 8
American Journal of Epidemiology|December 22, 1999
Reproductive history and stage of breast cancerJ Wohlfahrt, P K Andersen, H T Mouridsen, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|March 16, 2000
Variations in prognostic factors in primary breast cancer throughout the menstrual cycleN Kroman, S M Thorpe, J Wohlfahrt, et al.
Schizophrenia Research|May 18, 2001
Risk factors and confounders in the geographical clustering of schizophreniaE F Torrey, P B Mortensen, C B Pedersen, et al.
British Journal of Cancer|March 6, 2015
Mitochondrial dysfunction and risk of cancerM Lund, M Melbye, L J Diaz, et al.
BMJ (Clinical Research Ed.)|November 14, 1997
Time since childbirth and prognosis in primary breast cancer: population based studyN Kroman, J Wohlfahrt, K W Andersen, et al.
British Journal of Cancer|December 4, 1998
Parity, age at first childbirth and the prognosis of primary breast cancerN Kroman, J Wohlfahrt, K W Andersen, et al.
Scandinavian Journal of Infectious Diseases|May 12, 2001
Intensive exposure as a risk factor for severe polio: a study of multiple family casesN M Nielsen, P Aaby, J Wohlfahrt, et al.
BMJ (Clinical Research Ed.)|March 4, 2000
Factors influencing the effect of age on prognosis in breast cancer: population based studyN Kroman, M B Jensen, J Wohlfahrt, et al.
The Journal of General Virology|August 6, 2010
N-(3-Cyanophenyl)-2-phenylacetamide, an effective inhibitor of morbillivirus-induced membrane fusion with low cytotoxicityK Singethan, G Hiltensperger, S Kendl, et al.
Ugeskrift for Laeger|June 13, 2000
[Should all younger patients with breast cancer be offered adjuvant cytotoxic chemotherapy?]N T Kroman, M B Jensen, J Wohlfahrt, et al.
Pageof 8